TD Cowen lowered the firm’s price target on P3 Health Partners (PIII) to 25c from 90c and keeps a Hold rating on the shares. The firm updated its model to reflect 3Q24 results. The model assumes the company requires a $100m capital raise in 2025 to support continued operating losses.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter